NXSTAGE MEDICAL, INC. NXTM Income Statement

Nxstage medical, inc. (NXTM)

Income statement / TTM

Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues
425,991	415,164	404,410	393,941	383,353	378,009	374,000	366,378	363,169	357,739	345,848	336,123	326,230	314,995	308,762	301,501	291,040	282,627	274,006	263,429	258,999	253,278	246,825	242,132	234,133	228,884	223,643	217,256	205,268	193,373	0	0	0
Cost of revenues
242,021	237,120	231,147	225,653	222,526	218,608	217,342	214,393	213,285	212,318	207,986	204,652	199,670	194,566	191,667	185,598	178,101	172,747	166,569	160,926	159,025	155,084	151,329	149,324	145,514	144,473	142,756	139,648	133,870	127,753	0	0	0
Gross profit
183,970	178,044	173,263	168,288	160,827	159,401	156,658	151,985	149,884	145,421	137,862	131,471	126,560	120,429	117,095	115,903	112,939	109,880	107,437	102,503	99,974	98,194	95,496	92,808	88,619	84,411	80,887	77,608	71,398	65,620	0	0	0
Operating expenses:
Selling and marketing
71,374	70,809	69,519	68,234	67,079	66,119	65,394	63,878	62,411	60,832	59,234	58,528	58,216	57,644	56,715	55,385	53,736	52,237	50,364	47,842	45,265	43,059	41,261	40,485	39,531	38,809	38,260	37,550	36,477	35,596	0	0	0
Research and development
39,580	41,104	39,538	39,608	37,396	34,452	33,386	31,032	30,382	28,856	27,517	26,237	24,859	24,289	23,375	22,635	21,987	20,255	18,913	18,887	18,614	18,438	18,322	17,111	16,164	15,278	14,617	14,437	13,826	13,640	0	0	0
Distribution
35,629	35,058	34,183	32,484	30,842	29,840	29,169	28,579	28,202	27,653	26,893	26,211	25,679	25,592	25,822	26,001	25,437	24,336	22,888	21,246	20,314	19,719	19,264	18,888	18,463	18,441	18,290	17,916	17,086	16,009	0	0	0
General and administrative
40,175	43,406	43,323	41,813	39,684	34,857	33,700	32,781	33,319	34,169	34,243	35,124	34,609	34,346	34,160	34,069	34,071	33,483	33,323	32,326	30,911	30,041	28,732	27,530	26,929	25,716	24,246	23,206	22,773	22,708	0	0	0
Total operating expenses
186,758	190,377	186,563	182,139	175,001	165,268	161,649	156,270	154,314	151,510	147,887	146,100	143,363	141,871	140,072	138,090	135,231	130,311	125,488	120,301	115,104	111,257	107,579	104,014	101,087	98,244	95,413	93,109	90,162	87,953	0	0	0
Income (loss) from operations
-2,788	-12,333	-13,300	-13,851	-14,174	-5,867	-4,991	-4,285	-4,430	-6,089	-10,025	-14,629	-16,803	-21,442	-22,977	-22,187	-22,292	-20,431	-18,051	-17,798	-15,130	-13,063	-12,083	-11,206	-12,468	-13,833	-14,526	-15,501	-18,764	-22,333	0	0	0
Other income (expense):
Interest expense, net
-427	-526	-662	-756	-822	-898	-962	-1,000	-1,093	-1,161	-1,115	-1,115	-1,010	-953	-906	-863	-1,421	-1,004	-959	-611	-5,279	-5,415	-3,809	-2,766	3,876	5,036	4,750	4,714	4,689	4,651	0	0	0
Other income (expense), net
-1,156	-1,239	-888	-863	-508	-880	-968	-930	-962	-381	65	561	530	285	231	-10	-73	-205	-198	-397	-358	-203	-272	-148	-64	-223	-314	-288	-683	-207	0	0	0
Total other expense
-1,583	-1,765	-1,550	-1,619	-1,330	-1,778	-1,930	-1,930	-2,055	-1,542	-1,050	-554	-480	-668	-675	-873	-870	-909	-857	-1,008	-911	-620	-1,995	-2,914	-3,940	-5,259	-5,064	-5,002	-5,372	-4,858	0	0	0
Net income (loss) before income taxes
-4,371	-14,098	-14,850	-15,470	-15,504	-7,645	-6,921	-6,215	-6,485	-7,631	-11,075	-15,183	-17,283	-22,110	-23,652	-23,060	-23,162	-21,340	-18,908	-18,806	-16,041	-13,683	-14,078	-14,120	-16,408	-19,092	-19,590	-20,503	-24,136	-27,191	0	0	0
Provision for (benefit from) income taxes
1,169	1,126	732	-145	-71	-216	154	1,102	1,214	1,180	1,105	1,077	1,150	1,155	1,214	1,253	1,353	1,327	-31	-245	-292	-338	925	1,033	945	957	946	899	866	789	0	0	0
Net income (loss)
-5,540	-15,224	-15,582	-15,325	-15,433	-7,429	-7,075	-7,317	-7,699	-8,811	-12,180	-16,260	-18,433	-23,265	-24,866	-24,313	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Less: Net loss attributable to noncontrolling interests
-104	-462	-1,320	-1,333	-2,113	-2,388	-2,391	-2,546	-1,855	-1,446	-1,220	-918	-909	-722	-537	-367	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Net income (loss) attributable to NxStage Medical, Inc.
-5,436	-14,762	-14,262	-13,992	-13,320	-5,041	-4,684	-4,771	-5,844	-7,365	-10,960	-15,342	-17,524	-22,543	-24,329	-23,946	-24,270	-22,550	-18,842	-18,561	-15,749	-13,345	-15,003	-15,153	-17,353	-20,049	-20,536	-21,402	-25,002	-27,980	0	0	0
Add: Accretion to redemption value of noncontrolling interests
0	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) attributable to common stockholders
0	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) per common share:
Net loss per share, basic (in dollars per share)
0.01	-	-	-	-0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share, diluted (in dollars per share)
0.00	-	-	-	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted-average shares outstanding:
Weighted-average shares outstanding, basic (in shares)
66,660	-	-	-	66,082	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted-average shares outstanding, diluted (in shares)
68,009	-	-	-	66,082	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share, basic and diluted (in dollars per share)
-	-0.04	-0.02	-	-	-0.03	-0.02	-0.02	0.00	-0.03	-0.02	-0.04	-0.03	-0.08	-0.09	-0.07	-0.11	-0.12	-0.09	-0.09	-0.08	-0.06	-0.08	-0.04	-0.04	-0.09	-0.09	-0.08	-0.10	-0.10	-0.11	-0.17	-0.17
Weighted-average shares outstanding, basic and diluted (in shares)
-	66,552	66,355	-	-	65,821	65,275	64,835	64,638	64,428	64,179	63,884	63,528	63,288	62,836	62,275	61,804	61,469	61,252	-	-	60,036	59,381	-	-	-	-	-	-	-	-	-	-
Other comprehensive income (loss):
Unrealized income (loss) on derivative instruments, net of income taxes
-1,198	-2,397	-722	1,001	1,482	2,138	511	-802	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income (loss)
434	679	-1,404	-1,427	-951	-610	737	1,268	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted-average shares outstanding, basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	60,675	-	-	-	58,945	57,733	55,773	55,003	54,428	54,014	53,423	48,049	47,492
Total other comprehensive income (loss)
-1,632	-3,076	682	2,428	2,433	2,748	-226	-2,070	-377	-1,128	-2	-1,839	-2,909	0	0	-	0	-	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Total comprehensive income (loss)
-7,172	-18,300	-14,900	-12,897	-13,000	-4,681	-7,301	-9,387	-8,076	-9,939	-12,182	-18,099	-21,801	-26,954	-28,228	-26,717	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Less: Comprehensive loss attributable to noncontrolling interests
-104	-462	-1,320	-1,333	-2,113	-2,388	-2,391	-2,546	-1,855	-1,446	-1,220	-918	-909	-722	-537	-367	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Other comprehensive income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	0	-	-	-	-	-	-
Foreign currency gain (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-
Other gain (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-
Total comprehensive income (loss) attributable to NxStage Medical, Inc.
-7,068	-17,838	-13,580	-11,564	-10,887	-2,293	-4,910	-6,841	-6,221	-8,493	-10,962	-17,181	-20,892	-26,232	-27,691	-26,350	-25,021	-21,894	-19,063	-18,819	-16,100	-13,242	-14,493	-14,615	-16,980	-20,636	-20,745	-21,555	0	0	0	-	-